Etanercept Combined with Glucocorticoid and Gamma Globulin for Treating Children with Toxic Epidermal Necrolysis: A Case Report

Clin Cosmet Investig Dermatol. 2024 Jan 23:17:167-171. doi: 10.2147/CCID.S440476. eCollection 2024.

Abstract

Toxic epidermal necrolysis (TEN) is a type of drug eruption in dermatology emergencies that is rare in clinical practice but has a high mortality rate. The main causes are drug and viral infections. Unfortunately, no expert consensus on treating this disease exists, and a standard therapy is absent. Up to now, glucocorticoids combined with gamma globulin are commonly used in clinical practice, but their efficacy is highly controversial. This study reports on a 7-year-old girl with TEN who did not respond to traditional therapy, such as methylprednisolone combined with gamma globulin, but was finally cured with an additional low-dose etanercept. The results showed that etanercept therapy in paediatric TEN is safe, reliable and worth recommending.

Keywords: child toxic epidermal necrolysis; etanercept; gamma globulin; glucocorticoids.

Publication types

  • Case Reports

Grants and funding

The authors have received no financial support for the research, authorship, or publication of this manuscript.